Mercaptopurine increases metabolite production in fibroblasts
Cell-based study · hTERT-BJ1 fibroblasts [1]
In hTERT-BJ1 fibroblasts, Mercaptopurine treatment increased production of L-lactate or β-hydroxybutyrate (β-HB) compared with vehicle.
| Endpoint | Reported result | Reference |
|---|---|---|
| L-lactate and β-hydroxybutyrate (β-HB) concentration | Reported result an increase in their production of L-lactate or β-HB compared to vehicle | [1] |
Literature-Reported Treatment Conditions
- Exposure duration
- 48 or 72 h
- Method
- drug treatments were added
- Reported limits
- Not stated in the sentences used: dose, vehicle.
Methods and source locations
Compound reported in the paper: Mercaptopurine; Compound label in the paper: 6-Mercaptopurine
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
RESULTS (S3); MATERIALS AND METHODS > L-lactate assay, β-hydroxybutyrate assay, glucose consumption (S85, S91)
L-lactate and β-hydroxybutyrate (β-HB) concentration: L-lactate and β-hydroxybutyrate (β-HB) concentration; comparator: vehicle — RESULTS (S3)